For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of AARTI PHARMALABS. For more details, see the AARTI PHARMALABS quarterly results and AARTI PHARMALABS share price.
1 Day | % | 1.9 |
No. of shares | m | 90.63 |
1 Week | % | -1.4 |
1 Month | % | 15.3 |
1 Year | % | 25.5 |
52 week H/L | Rs | 594.9/321.0 |
No. of Mths Year Ending |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
AARTI PHARMALABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 397 | ||
Low | Rs | NA | NA | NA | 269 | ||
Sales per share (Unadj.) | Rs | 0 | 0 | 47,997.7 | 214.6 | ||
Earnings per share (Unadj.) | Rs | -0.8 | -0.2 | 4,890.0 | 21.3 | ||
Diluted earnings per share | Rs | -0.0 | -0.0 | 13.5 | 21.4 | ||
Cash flow per share (Unadj.) | Rs | -0.8 | -0.2 | 6,574.8 | 28.3 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 2.00 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 2.00 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0.6 | ||
Book value per share (Unadj.) | Rs | 9.2 | 9.1 | 53,646.6 | 172.0 | ||
Adj. book value per share | Rs | 0.0 | 0.0 | 148.0 | 172.0 | ||
Shares outstanding (eoy) | m | 0.25 | 0.25 | 0.25 | 90.63 | ||
Price / Sales ratio | x | 0 | 0 | 0 | 1.6 | ||
Avg P/E ratio | x | 0 | 0 | 0 | 15.6 | ||
P/CF ratio (eoy) | x | 0 | 0 | 0 | 11.8 | ||
Price / Book Value ratio | x | 0 | 0 | 0 | 1.9 | ||
Dividend payout | % | 0 | 0 | 0 | 9.4 | ||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 30,178 | ||
Total wages/salary | Rs m | 0 | 0 | 852 | 1,297 |
AARTI PHARMALABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | 11,999 | 19,452 | ||
Other income | Rs m | 0 | 0 | 42 | 23 | ||
Total revenues | Rs m | 0 | 0 | 12,041 | 19,476 | ||
Gross profit | Rs m | 0 | 0 | 2,053 | 3,421 | ||
Depreciation | Rs m | 0 | 0 | 421 | 625 | ||
Interest | Rs m | 0 | 0 | 120 | 211 | ||
Profit before tax | Rs m | 0 | 0 | 1,554 | 2,608 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | 0 | 0 | 331 | 673 | ||
Profit after tax | Rs m | 0 | 0 | 1,223 | 1,935 | ||
Gross profit margin | % | 0 | 0 | 17.1 | 17.6 | ||
Effective tax rate | % | 0 | 0 | 21.3 | 25.8 | ||
Net profit margin | % | 0 | 0 | 10.2 | 9.9 |
AARTI PHARMALABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 3 | 3 | 10,281 | 11,558 | ||
Current liabilities | Rs m | 0 | 0 | 5,807 | 5,916 | ||
Net working cap to sales | % | 0 | 0 | 37.3 | 29.0 | ||
Current ratio | x | 0 | 11.4 | 1.8 | 2.0 | ||
Inventory Days | Days | 0 | 0 | 13 | 16 | ||
Debtors Days | Days | 0 | 0 | 1,146 | 826 | ||
Net fixed assets | Rs m | 0 | 0 | 10,118 | 10,752 | ||
Share capital | Rs m | 3 | 3 | 3 | 453 | ||
"Free" reserves | Rs m | 0 | 0 | 13,409 | 15,132 | ||
Net worth | Rs m | 2 | 2 | 13,412 | 15,585 | ||
Long term debt | Rs m | 0 | 0 | 6 | 2 | ||
Total assets | Rs m | 3 | 3 | 20,399 | 22,309 | ||
Interest coverage | x | 0 | 0 | 14.0 | 13.4 | ||
Debt to equity ratio | x | 0 | 0 | 0 | 0 | ||
Sales to assets ratio | x | 0 | 0 | 0.6 | 0.9 | ||
Return on assets | % | -7.5 | -1.8 | 6.6 | 9.6 | ||
Return on equity | % | -8.1 | -2.0 | 9.1 | 12.4 | ||
Return on capital | % | -8.1 | -2.0 | 12.5 | 18.1 | ||
Exports to sales | % | 0 | 0 | 39.2 | 32.0 | ||
Imports to sales | % | 0 | 0 | 12.7 | 10.1 | ||
Exports (fob) | Rs m | 0 | 0 | 4,706 | 6,231 | ||
Imports (cif) | Rs m | 0 | 0 | 1,528 | 1,959 | ||
Fx inflow | Rs m | 0 | 0 | 4,706 | 6,231 | ||
Fx outflow | Rs m | 0 | 0 | 1,583 | 2,061 | ||
Net fx | Rs m | 0 | 0 | 3,123 | 4,171 |
AARTI PHARMALABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -0 | 0 | -437 | 2,630 | ||
From Investments | Rs m | 0 | 0 | -1,387 | -1,578 | ||
From Financial Activity | Rs m | 3 | 0 | 2,604 | -1,635 | ||
Net Cashflow | Rs m | 3 | 0 | 779 | -583 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Rashesh C Gogri | COMP SEC: Nikhil Natu | YEAR OF INC: 2019 | BSE CODE: 543748 | FV (Rs): 5 | DIV YIELD (%): 0.4 |
More Pharmaceuticals Company Fact Sheets: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
Compare AARTI PHARMALABS With: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.